Last update 08 May 2025

Ginkgo Leaves Capsule

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesEye Diseases
Active Indication
Angina PectorisBrain InfarctionCoronary Artery Disease+ [1]
Inactive Indication-
Originator Organization
Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.
Active Organization
Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (26 May 2020),
Angina PectorisBrain InfarctionCoronary Artery Disease
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Ginkgo Leaves Capsule
CTR20160043
/ RecruitingPhase 3
银杏叶胶囊对原发性开角型青光眼-瘀血阻络证视功能影响作用的随机、双盲、安慰剂平行对照、多中心临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial on the effects of Ginkgo biloba capsule on visual function in primary open-angle glaucoma with blood stasis and obstruction of collaterals
100 Clinical Results associated with Ginkgo Leaves Capsule
Login to view more data
100 Translational Medicine associated with Ginkgo Leaves Capsule
Login to view more data
100 Patents (Medical) associated with Ginkgo Leaves Capsule
Login to view more data
100 Deals associated with Ginkgo Leaves Capsule
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Angina Pectoris
China
Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.
26 May 2020
Brain Infarction
China
Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.
26 May 2020
Coronary Artery Disease
China
Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.
26 May 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glaucoma, Open-AnglePhase 3
China
Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.Shanghai Xinyi Bailuda Pharmaceutical Co. Ltd.
22 Jul 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free